Beken Bio

Beken Bio creates minimally invasive liquid biopsy tests that detect cancer biomarkers in blood before symptoms appear. Their proprietary 3D REVEAL™ engine uses a 3D cell growth platform and AI-driven protein signature analysis to identify tumor-specific extracellular vesicles. The resulting diagnostic assays aim to enable earlier treatment decisions and improve survival rates.

Traction –/10

HQ unknown

350+ followers

Biotechnology
Healthcare Technology

Updated 5 months ago

Funding

Raised to date

$250KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Beken Bio creates minimally invasive liquid biopsy tests that detect cancer biomarkers in blood before symptoms appear. Their proprietary 3D REVEAL™ engine uses a 3D cell growth platform and AI-driven protein signature analysis to identify tumor-specific extracellular vesicles. The resulting diagnostic assays aim to enable earlier treatment decisions and improve survival rates.